G. Daniel Grass MD, PhD (@gdgrass) header
G. Daniel Grass MD, PhD (@gdgrass) profile picture

Genitourinary Radiation Oncologist, Holman-trained @ Moffitt. Student of bladder and penile cancer. Trying to be a physician-scientist. Tweets=own

Tampa, FL
Joined September 2017
Photo by G. Daniel Grass MD, PhD (@gdgrass)Photo by G. Daniel Grass MD, PhD (@gdgrass)Photo by G. Daniel Grass MD, PhD (@gdgrass)Photo by G. Daniel Grass MD, PhD (@gdgrass)Photo by G. Daniel Grass MD, PhD (@gdgrass)Photo by G. Daniel Grass MD, PhD (@gdgrass)Photo by G. Daniel Grass MD, PhD (@gdgrass)Photo by G. Daniel Grass MD, PhD (@gdgrass)Photo by G. Daniel Grass MD, PhD (@gdgrass)Photo by G. Daniel Grass MD, PhD (@gdgrass)
Congrats!!
Congrats to Dr Pow-Sang for winning the Florida Urologic Lifetime Achievement Award
1
5
294
Awesome work @NakashimaJustyn! One of our chiefs @MoffittRadOnc soon to provide excellent care to many patients in the Orlando area 💪🏻
From #ASTRO25 : Justyn Nakashima, DO (@NakashimaJustyn) shares institutional outcomes of SBRT for extracranial oligometastatic renal cell carcinoma during the poster Q&A. Results indicate that SBRT is safe and effective, delaying systemic therapy while maintaining high LC and PFS. #MoffittASTRO25
3
11
1,279
Strong 💪🏻 work from a stellar resident @celinachiodo presenting @MoffittNews early experience with online hypofx adaptive bladder radiation. Awesome support by @MoffittRadOnc physics in making this an option for our patients
1
5
1
16
1,252
Great job @DK_18621 presenting your research on the use of ctDNA in post-TMT surveillance. Much to learn with this data. 🚨 Rising ⭐️ @MoffittRadOnc @MoffittNews
1
2
9
286
Strong work @ninaobertopp & @MoffittNews Pilon-Thomas lab on how 8 Gy x 1 may open options for RT-cellular therapy integration! @MoffittRadOnc @RRS_RadRes @QuadShotNews Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-... sciencedirect.com/science/ar…
3
5
17
919
Received this letter today. Extremely honored to join this laser-focused group of clinicians/scientists/advocates that work tirelessly to eradicate #bladdercancer. Much to learn & much to do for our patients. Thank you @IBCG_BladderCA for the opportunity.
1
4
18
601
1/n @MoffittNews experience in small cell/NE bladder cancer. Project led by former @MoffittRadOnc chiefs @LiveringhouseCL (now in N. Dakota) @A_CT_SimMDJD (The Ohio St) and @LaurenLinkowski (U Penn rad onc resident).See paper at authors.elsevier.com/c/1js1A…
1
4
15
1,165
2/n Similar findings to other large NE bladder studies: 1) NAC -> local therapy (surgery or RT) best; 2) N+ patients need better options; 3) ypN0 -> good survival; 4) no diff based on involved LN histology; 4) brain met rate ~11%.
1
3
134
Congrats @UrogerliMD. Your tireless efforts are paying off for bladder patients. Keep it up 💪🏻
Final results of #CORE001 trial out now @NatureMedicine (1/14) 35 pts with BCG-UR CIS treated w/ Creto + pembro 👉12mo CR (per RBB) = 57.1% (ITT) 👉24mo CR = 54% *(Auth Corr) 👉No patient progressed to MIBC 👉No synergistic toxicity @garysteinbergmd nature.com/articles/s41591-0…
1
5
571
2/n: First, we used PSCC cell line translatomics to estimate active transcript->protein processing and overlayed this w/ a public surfaceome gene set identified by ML and mass-spec (SURFY). Notable differences in functional classes seen between cell types.
1
68
Great work @gatechatl and team!
Fresh off the press. PATH‑SURVEYOR: pathway level survival enquiry for immuno‑oncology and drug repurposing rdcu.be/dfCGf Congrats to Alyssa Obermayer and coauthors @ATarhiniMDPhD @xuefwang @gdgrass @DarwinChangZ @MoffittResearch @BMCBioinfo
176
Thanks for sharing your amazing talent @julian_lage and trio last night @CenterStageAtl Truly masterful performance.
Watch out #radonc @LaurenLinkowski is a rising super ⭐️. Great job!
This Post is from an account that no longer exists. Learn more
2
3
Great meeting! Lots of cross-disciplinary innovation happening. #momentum to do better for our patients.
This Post is from an account that no longer exists. Learn more
1
5
1/n: TWEETORIAL - on our work in @ASTRO_org #RedJournal relating immune contexture & #radiation sensitivity in >10k primary tumors. HUGE efforts by @HeikoEnderling @jc_atlantis @jtorresroca @KAhmedMD @DrJamesMule & more @MoffittRadOnc @MoffittNews link -> https://teapawt.org/t.co/4jyZmtxu1B
3
15
3
35
2/n: First, we used t-SNE on bulk gene expression data from individual primary tumors (n=10,469) to characterize tumor types by transcriptome - as expected most tumors cluster by their higher order transcription programs and tissue of origin
1
1
3
Interesting #GU22 abstract. No severe tox seen with hypofx RT to bladder with IO. Clearly more to learn about this combo
3
Interim analysis of multi-site (@HuntsmanCancer & @MoffittNews) ph 2 NEXT trial (TMT -> adjvnt nivo) @ASCO #GU22 Great collab w/ @SumatiNysumi. Strong #multiDcare w/@UrogerliMD @michael_poch @rohitjainMD for high risk #bladdercancer pts. Much more to learn @BladderCancerUS
2
8
First multi-D bladder cancer clinic @MoffittNews with @LoganZemp. Working together to improve #Bladdercancer care for our patients - right treatment for the right patient. @MoffittRadOnc @MoffittGUOnc grateful for support of @JulioPowSangMD @michael_poch @KOSJ12 @sgilbert1973
4
5
2
41
BRAVOS!!!! #ForTheA FOR LIFE!! CONGRATS! AGAINST TONS OF ADVERSITY, <.500 @ MID SEASON...PERSEVERANCE, CHARACTER, TALENT, SWEAT & TEARS. 22 YEARS AGO WAS THE LAST TIME WE SAW THIS CHANCE. SO HAPPY!!
THE ATLANTA BRAVES ARE WORLD SERIES CHAMPIONS! #BattleATL | #ForTheA
4